28Oct/13

Fewer 'Brain Dead' Diagnoses After Brain Injuries May Explain Stagnant Organ … – Medical Daily

Fewer ‘Brain Dead’ Diagnoses After Brain Injuries May Explain Stagnant Organ
Medical Daily
Researchers involved with the study point out that donation after neurologic death (i.e. brain death) accounts for half of kidney transplants, three-quarters of liver transplants, 90 percent of lung and pancreas transplants, and all heart and small

28Oct/13

Brain death on the decline in Canada: study – The Globe and Mail


The Globe and Mail

Brain death on the decline in Canada: study
The Globe and Mail
From 2002 to 2012, the proportion of brain-injured patients in southern Alberta who deteriorated to neurologic death (brain death) declined from 8.1 per cent to 4.2 per cent – a 50-per-cent reduction, noted study author Dr. Andreas Kramer, a clinical
Brain death decline may explain fall in organ donationsCBC.ca
Brain death rates dropToronto Star
Fewer ‘brain dead’ patients means drop in organ donationsCanada.com
Medical Daily –MedPage Today
all 9 news articles »
28Oct/13

Loma Linda University Children's Hospital Celebrates 20 Years with Public … – PR Web (press release)

Loma Linda University Children’s Hospital Celebrates 20 Years with Public
PR Web (press release)
LLUCH has pioneered and continues to lead in the area of infant heart transplantation, and has received acclaim for its many programs to treat pediatric patients, including proton treatment for cancer, trauma care, physical rehabilitation, intensive

and more »

28Oct/13

The Non-Hodgkin's Lymphoma Drug Market Will Nearly Double to More Than … – The Providence Journal

The Non-Hodgkin’s Lymphoma Drug Market Will Nearly Double to More Than
The Providence Journal
The Pharmacor advisory service entitled Non-Hodgkin’s Lymphoma finds that sales of rituximab dominate the current market, and will continue to do so through 2022, regardless of biosimilar rituximab entry. Teva Pharmaceutical Industries’ 

and more »